Article
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.
British journal of clinical pharmacology - 1 Jul 2014
Noetzli Muriel, Guidi Monia, Ebbing Karsten, Eyer Stephan, Wilhelm Laurence, Michon Agnès, Thomazic Valérie, Stancu Ioana, Alnawaqil Abdel-Messieh, Bula Christophe, Zumbach Serge, Gaillard Michel, Giannakopoulos Panteleimon, von Gunten Armin, Csajka Chantal, Eap Chin B
Abstract excerpt
AIMS: A large interindividual variability in plasma concentrations has been reported in patients treated with donepezil, the most frequently prescribed antidementia drug. We aimed to evaluate clinical and genetic factors influencing donepezil disposition in a patient population recruited from a naturalistic setting. METHODS: A population pharmacokinetic study was performed including data from 129 older patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
